ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Alpha Cognition Inc

Alpha Cognition Inc (ACOG)

0,24
0,00
( 0,00% )
Mis à jour : 01:00:00

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,24
Prix Achat
0,23
Prix Vente
0,30
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,24 Plage de 52 semaines 0,24
Cap du marché
Clôture Veille
0,24
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
118 208 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,86
Bénéfice par action (BPA)
-0,12
Chiffre d'affairess
-
Bénéfice net
-13,77M

À propos de Alpha Cognition Inc

Secteur
Pharmaceutical Preparations
Industrie
Finance Services
Siège social
Vancouver, British Columbia, Can
Fondé
2021
Alpha Cognition Inc est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker ACOG. Le dernier cours de clôture d'Alpha Cognition était de $0,24. Au cours de la dernière année, les actions de Alpha Cognition ont été négociées dans une fourchette de prix de $ 0,24 à $ 0,24.

Alpha Cognition compte actuellement 118 208 000 actions en circulation. La capitalisation boursière d'Alpha Cognition est de $28,37 million. Alpha Cognition a un ratio cours/bénéfice (ratio PE) de -0.86.

ACOG Dernières nouvelles

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update

Alpha Cognition Inc. (OTCQB: ACOG) (CSE: ACOG) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today...

Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Provides Private Placement Update

Not for distribution in the United States or to U.S. newswire services Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company...

Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Announces Withdrawal of Marketed Public Offering

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...

Alpha Cognition Announces Marketed Offering

NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...

Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating...

Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 23rd Life...

Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.240.240.2400CS
4000.240.240.2400CS
12000.240.240.2400CS
26000.240.240.2400CS
52000.240.240.2400CS
156-0.86-78.18181818181.11.350.2179570.68559498CS
260-1.13-82.48175182481.372.490.21111700.9397552CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SCOTScottie Resources Corp
$ 0,99
(500,00%)
1,18k
SCLTSearchlight Resources Inc
$ 0,01
(100,00%)
32k
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
1,5k
REEE Tech Resources Inc
$ 0,045
(80,00%)
5k
RYORio Silver Inc
$ 0,025
(66,67%)
19,54k
MAHMarksmen Energy Inc
$ 0,005
(-50,00%)
1,76M
VPIVitality Products Inc
$ 0,015
(-40,00%)
30k
GKOGeekco Technologies Corporation
$ 0,03
(-40,00%)
100k
VLXVelox Energy Materials Inc
$ 0,08
(-33,33%)
520
ALYAnalytixInsight Inc
$ 0,01
(-33,33%)
25k
ALALX Resources Corp
$ 0,03
(20,00%)
2,89M
QNCQuantum Emotion Corp
$ 0,195
(8,33%)
2,12M
MAHMarksmen Energy Inc
$ 0,005
(-50,00%)
1,76M
BARUBaru Gold Corp
$ 0,09
(28,57%)
1,69M
FUUF3 Uranium Corp
$ 0,255
(8,51%)
1,65M
Aucune Discussion Trouvée
Ajouter une Discussion